[1]
L. A. Atramentova, “ASSESSING THE RISK OF NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ”, PEP, vol. 51, no. 1, pp. 21-27, Jun. 2021.